Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Gallium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ionetix’s Generics Gallium Gozetotide Receives Approval in US
    Ionetix’s Generics Gallium Gozetotide Receives Approval in US

    14 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219189

    FDA
    14 May 2026
    Share Share
    First U.S. Patient Dosed In BiPASS Phase 3 Prostate Cancer Study
    First U.S. Patient Dosed In BiPASS Phase 3 Prostate Cancer Study

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220521/0/en/First-U-S-Patient-Dosed-in-BiPASS-Phase-3-Prostate-Cancer-Diagnosis-Study.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Curium’s GalenVita Receives Approval in Europe
    Curium’s GalenVita Receives Approval in Europe

    08 Jan 2026

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/galenvita

    EMA
    08 Jan 2026
    Share Share
    Methodist’s Generics Gallium68 Edotreotide Receive Approval in US
    Methodist’s Generics Gallium68 Edotreotide Receive Approval in US

    10 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218845

    FDA
    10 Oct 2025
    Share Share
    CMS Grants Transitional Pass-Through Status for Gozellix
    CMS Grants Transitional Pass-Through Status for Gozellix

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154891/0/en/CMS-Grants-Transitional-Pass-Through-Status-for-Gozellix.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Telix Begins Phase 3 BiPASS Trial: PSMA-PET for Prostate Cancer
    Telix Begins Phase 3 BiPASS Trial: PSMA-PET for Prostate Cancer

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3147425/0/en/Telix-Doses-First-Patient-in-Phase-3-BiPASS-Trial-PSMA-PET-Imaging-for-Prostate-Cancer-Diagnosis.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.